1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. Chronic Idiopathic Constipation Therapeutic Market, by Drug Class
6.1. Introduction
6.2. Bulk-forming Agents
6.3. Emollients
6.4. Laxatives
6.5. Osmotic Agents

7. Chronic Idiopathic Constipation Therapeutic Market, by Route of Administration
7.1. Introduction
7.2. Oral
7.3. Parental

8. Chronic Idiopathic Constipation Therapeutic Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Retail Pharmacies

9. California Chronic Idiopathic Constipation Therapeutic Market

10. Florida Chronic Idiopathic Constipation Therapeutic Market

11. Illinois Chronic Idiopathic Constipation Therapeutic Market

12. New York Chronic Idiopathic Constipation Therapeutic Market

13. Ohio Chronic Idiopathic Constipation Therapeutic Market

14. Pennsylvania Chronic Idiopathic Constipation Therapeutic Market

15. Texas Chronic Idiopathic Constipation Therapeutic Market

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. Astellas Pharma Inc.
17.2. Astellas Pharma, Inc.
17.3. Bayer AG
17.4. Boehringer Ingelheim GmbH
17.5. Boehringer Ingelheim International GmbH
17.6. Chugai Pharmaceuticals Co. Ltd.
17.7. Daewoong Pharmaceuticals Ltd.
17.8. Ferring Group
17.9. GlaxoSmithKline Plc
17.10. GlaxoSmithKline Plc.
17.11. Ironwood Pharmaceuticals
17.12. Ironwood Pharmaceuticals, Inc.
17.13. Pfizer, Inc.
17.14. Progenics Pharmaceuticals Inc.
17.15. Salix Pharmaceuticals
17.16. Sanofi S.A.
17.17. Sucampo Pharmaceuticals Inc.

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET: MARKET DYNAMICS
FIGURE 4. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2020 VS 2026 (%)
FIGURE 5. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2026
FIGURE 7. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY BULK-FORMING AGENTS, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY BULK-FORMING AGENTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 9. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY EMOLLIENTS, 2018-2026 (USD MILLION)
FIGURE 10. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY EMOLLIENTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 11. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY LAXATIVES, 2018-2026 (USD MILLION)
FIGURE 12. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY LAXATIVES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 13. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY OSMOTIC AGENTS, 2018-2026 (USD MILLION)
FIGURE 14. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY OSMOTIC AGENTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 15. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2026 (%)
FIGURE 16. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2026 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2026
FIGURE 18. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY ORAL, 2018-2026 (USD MILLION)
FIGURE 19. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY ORAL, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 20. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY PARENTAL, 2018-2026 (USD MILLION)
FIGURE 21. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY PARENTAL, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 22. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (%)
FIGURE 23. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2026
FIGURE 25. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2026 (USD MILLION)
FIGURE 26. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 27. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY ONLINE PHARMACIES, 2018-2026 (USD MILLION)
FIGURE 28. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY ONLINE PHARMACIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 29. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY RETAIL PHARMACIES, 2018-2026 (USD MILLION)
FIGURE 30. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY RETAIL PHARMACIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 31. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET: FPNV POSITIONING MATRIX
FIGURE 32. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 33. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY BULK-FORMING AGENTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY EMOLLIENTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY LAXATIVES, BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY OSMOTIC AGENTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY ORAL, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY PARENTAL, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY ONLINE PHARMACIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET SIZE, BY RETAIL PHARMACIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET: SCORES
TABLE 17. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET: BUSINESS STRATEGY
TABLE 18. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET: PRODUCT SATISFACTION
TABLE 19. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET: RANKING
TABLE 20. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 21. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET: MERGER & ACQUISITION
TABLE 22. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 23. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 24. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET: INVESTMENT & FUNDING
TABLE 25. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 26. UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION THERAPEUTIC MARKET: LICENSE & PRICING

Companies Mentioned

Astellas Pharma Inc.
Astellas Pharma, Inc.
Bayer AG
Boehringer Ingelheim GmbH
Boehringer Ingelheim International GmbH
Chugai Pharmaceuticals Co. Ltd.
Daewoong Pharmaceuticals Ltd.
Ferring Group
GlaxoSmithKline Plc
GlaxoSmithKline Plc.
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals, Inc.
Pfizer, Inc.
Progenics Pharmaceuticals Inc.
Salix Pharmaceuticals
Sanofi S.A.
Sucampo Pharmaceuticals Inc.